Search results
Showing 31 to 45 of 130 results for epilepsy
effectiveness of providing tailored psychological treatments for people with epilepsy? Any explanatory notes(if applicable) For a short...
immunomodulation strategies are effective in people with defined autoimmune epilepsy syndromes? Any explanatory notes(if applicable) For...
Transient loss of consciousness ('blackouts') in over 16s (QS71)
This quality standard covers assessing, diagnosing and referring people (aged 16 and over) who have had a transient loss of consciousness (often called a blackout). It describes high-quality care in priority areas for improvement.
View quality statements for QS71Show all sections
Sections for QS71
- Quality statements
- Quality statement 1: Initial assessment – recording the event, clinical history and physical examination
- Quality statement 2: Initial assessment – 12-lead electrocardiogram (ECG)
- Quality statement 3: Urgent specialist cardiovascular assessment within 24 hours of the initial assessment
- Quality statement 4: Initial assessment – unnecessary use of electroencephalogram (EEG)
- Quality statement 5: Driving advice
- Quality statement 6: Specialist cardiovascular investigation – ambulatory electrocardiogram (ECG)
- Update information
Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome (TA615)
Evidence-based recommendations on cannabidiol (Epidyolex) with clobazam for seizures associated with Lennox–Gastaut syndrome in people aged 2 years and older.
Question MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy Interventional procedures guidance Any explanatory...
Epicranial focal cortex stimulation for drug-resistant focal epilepsy
Topic prioritisation
This guideline covers assessing, diagnosing and managing physical health problems of people in prison. It aims to improve health and wellbeing in the prison population by promoting more coordinated care and more effective approaches to prescribing, dispensing and supervising medicines.
Autism spectrum disorder in under 19s: recognition, referral and diagnosis (CG128)
This guideline covers recognising and diagnosing autism spectrum disorder in children and young people from birth up to 19 years. It also covers referral. It aims to improve the experience of children, young people and those who care for them.
clinical and cost effectiveness of digital health technologies in people with epilepsy? Any explanatory notes(if applicable) For a short...
stimulation: What is the effectiveness of vagus nerve stimulation in treating epilepsy (including people with learning disabilities as a...
Contraception: advice for people taking anti-seizure medication (IND78)
This indicator covers the percentage of women under the age of 55 years who are taking antiseizure medications who have a record of information and counselling about contraception, conception and pregnancy in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM03
Awaiting development Reference number: GID-TA11069 Expected publication date: TBC
In development Reference number: GID-TA10664 Expected publication date: TBC
effectiveness of ketogenic diets in adults and children with drug-resistant epilepsy, and what factors affect the long-term maintenance...